Astrana Health, Inc. (ASTH): who owns it and who trades it
As of Nov 16, 2026, no open-market insider purchases or sales of ASTH were reported in the last 12 months. 2 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Astrana Health
From the latest filingsOverall: more buying than selling. Funds and famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns ASTH
208 funds and institutions reported ASTH shares worth $1.6B at the end of Q2 2026, about 63% of the company. The largest holder is BlackRock, Inc. with 12.4%.
Funds and institutions (13F) 63%Everyone else 37%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 6.90M | 12.41% | $320M | +12% |
| Vanguard Portfolio Management LLC | 2.61M | 4.69% | $121M | +14% |
| California State Teachers Retirement System | 2.37M | 4.26% | $51M | +4512% |
| Vanguard Capital Management LLC | 1.95M | 3.50% | $90.3M | +14% |
| State Street Corp | 1.74M | 3.13% | $80.7M | +5% |
| 325 Capital LLC | 1.61M | 2.90% | $74.9M | -12% |
| Dimensional Fund Advisors LP | 1.47M | 2.64% | $68.1M | +7% |
| Wellington Management Group LLP | 1.29M | 2.32% | $60M | -4% |
| Geode Capital Management, LLC | 1.17M | 2.10% | $54.2M | +13% |
| Bank of America Corp | 852,145 | 1.53% | $39.5M | +48% |
| FMR LLC (Fidelity) | 685,922 | 1.23% | $31.8M | +65% |
| Wells Fargo & Company | 664,940 | 1.20% | $30.9M | +546% |
| Charles Schwab Investment Management Inc | 652,669 | 1.17% | $30.3M | +1% |
| Sixth Street Partners Management Company, L.P. | 652,669 | 1.17% | $30.3M | – |
| Ameriprise Financial Inc | 512,110 | 0.92% | $23.8M | -7% |
| Northern Trust Corp | 505,044 | 0.91% | $23.4M | +15% |
| Diamond Hill Capital Management, LLC (Investment Advisor) | 475,941 | 0.86% | $22.1M | -13% |
| Royce & Associates LP | 472,480 | 0.85% | $21.9M | +19% |
| SteelPeak Wealth, LLC | 464,937 | 0.84% | $21.6M | -17% |
| Morgan Stanley | 433,508 | 0.78% | $20.1M | +28% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
No ASTH insider reported an open-market purchase or sale in the last 12 months.
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
ASTH short interest
Moderate short interest. 5.4% of ASTH shares are sold short: about 1 share in 19. Over the last 12 reports the number of shares short went up 10%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 2.99M ASTH shares were sold short, 5.4% of the shares outstanding, down 0.5% from the report before. At the average daily volume of 243,777 shares, buying them all back would take about 12.3 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 2.99M | 5.37% | -1% | 243,777 | 12.3 |
| Oct 15, 2026 | 3.01M | 5.40% | -2% | 340,295 | 8.8 |
| Sep 30, 2026 | 3.09M | 5.54% | -6% | 531,954 | 5.8 |
| Sep 15, 2026 | 3.27M | 5.87% | -0% | 279,499 | 11.7 |
| Aug 31, 2026 | 3.28M | 5.89% | +3% | 335,914 | 9.8 |
| Aug 14, 2026 | 3.18M | 5.71% | +13% | 567,219 | 5.6 |
| Jul 31, 2026 | 2.83M | 5.09% | +6% | 573,335 | 4.9 |
| Jul 15, 2026 | 2.68M | 4.82% | +0% | 685,812 | 3.9 |
| Jun 30, 2026 | 2.67M | 4.81% | +13% | 870,387 | 3.1 |
| Jun 15, 2026 | 2.36M | 4.24% | -2% | 521,593 | 4.5 |
| May 29, 2026 | 2.40M | 4.31% | -12% | 389,740 | 6.2 |
| May 15, 2026 | 2.72M | 4.88% | -5% | 534,143 | 5.1 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded ASTH
Since Nov 17, 2024, 1 member of Congress reported 1 purchase and 1 sale of ASTH. The latest was a purchase by Judy Chu on Aug 19, 2025, reported Aug 30, 2025.
Purchases 1Sales 1
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Aug 19, 2025 | Judy Chu (D-CA) | Purchase | $100K–$250K | Spouse | Aug 30, 2025 | Report |
| Aug 19, 2025 | Judy Chu (D-CA) | Sale | $100K–$250K | Spouse | Aug 30, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Astrana Health company events
Astrana Health filed 15 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership, cyberattack). The latest was on Nov 5, 2026.
- Nov 5, 2026ResultsReleased financial results. Filing
- Sep 23, 2026AnnouncementShared information with investors. Filing
- Sep 23, 2026CyberattackMaterial Cybersecurity Incident. Filing
- Sep 15, 2026AnnouncementShared information with investors. Filing
- Aug 6, 2026ResultsReleased financial results. Filing
- Jul 13, 2026AnnouncementShared information with investors. Filing
- Jul 1, 2026LeadershipGlenn Sobotka, the Chief Accounting Officer and principal accounting officer of Astrana Health, Inc., and the Company agreed that Mr. Sobotka will retire from his positions with the Company effective as of August 7, 2026. Filing
- Jun 10, 2026LeadershipThe stockholders of Astrana Health, Inc. approved the Astrana Health, Inc. Amended and Restated 2024 Equity Incentive Plan (as amended and restated, the “2024 Plan”) at the 2026 Annual Meeting of Stockholders of the Company held on June 10, 2026. Filing
- May 12, 2026LeadershipDinesh Kumar, M.D., the Chief Medical Officer of Astrana Health, Inc., notified the Company of his intention to resign, effective as of June 1, 2026. Filing
- May 12, 2026AnnouncementShared information with investors. Filing
- May 7, 2026ResultsReleased financial results. Filing
- Mar 30, 2026AnnouncementAstrana Health, Inc. filed a Current Report on Form 8-K, as amended by a Form 8-K/A filed on September 11, 2025, to report that it had completed the acquisition of all of the outstanding equity interests of Prospect Health Plan, Inc. and Alta Newport Hospital, LLC (d/b/a Foothill Regional Medical… Filing
- Mar 4, 2026AnnouncementShared information with investors. Filing
- Mar 2, 2026AnnouncementThe Company announced that the Board of Directors has increased the maximum aggregate amount of shares of the Company’s common stock that may be purchased under the Company’s existing share repurchase program from $50 million to $100 million. Filing
- Jan 12, 2026AnnouncementShared information with investors. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Astrana Health financials
Famous investors that hold ASTH
2 of the 50 well-known investors we track reported holding ASTH in their latest 13F filing. The largest position is Ken Griffin's, worth $6.2M.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 175,286 | $6.2M | 0.0% | +599% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 79,946 | $2.8M | 0.0% | +7% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named ASTH in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Oct 30, 2026 | Vanguard Portfolio Management | 13G/A | 4.7% |
| Oct 30, 2026 | Vanguard Portfolio Management | 13G/A | 4.7% |
Questions about Astrana Health, Inc. (ASTH) stock
Who owns the most ASTH stock?
The largest reported owner of Astrana Health, Inc. (ASTH) is BlackRock, Inc., with 12.4% of the company. In total, 208 funds and institutions reported holding ASTH at the end of Q2 2026, together about 63% of the shares. See the largest owners.
Are ASTH insiders buying or selling?
No ASTH insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.
What is the short interest in ASTH?
As of Oct 30, 2026, 2.99M ASTH shares were sold short, 5.4% of the shares outstanding, down 0.5% from the report before. At the average daily volume of 243,777 shares, buying them all back would take about 12.3 trading days (days to cover). See the history.
Have members of Congress traded ASTH?
Yes. 1 member of Congress reported 1 purchase and 1 sale of ASTH since Nov 17, 2024. The latest was reported on Aug 30, 2025. See the trades.
Which famous investors hold ASTH?
2 of the 50 well-known investors we track reported ASTH in their latest 13F filing, including Ken Griffin, Jim Simons. The largest position is worth $6.2M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.